Intranasal insulin prevents anesthesia-induced cognitive impairment and chronic neurobehavioral changes

31Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

General anesthesia increases the risk for cognitive impairment post operation, especially in the elderly and vulnerable individuals. Recent animal studies on the impact of anesthesia on postoperative cognitive impairment have provided some valuable insights, but much remains to be understood. Here, by using mice of various ages and conditions, we found that anesthesia with propofol and sevoflurane caused significant deficits in spatial learning and memory, as tested using Morris Water Maze (MWM) 2-6 days after anesthesia exposure, in aged (17-18 months old) wild-type (WT) mice and in adult (7-8 months old) 3xTg-AD mice (a triple transgenic mouse model of Alzheimer's disease (AD)), but not in adult WT mice. Anesthesia resulted in long-term neurobehavioral changes in the fear conditioning task carried out 65 days after exposure to anesthesia in 3xTg-AD mice. Importantly, daily intranasal administration of insulin (1.75 U/mouse/day) for only 3 days prior to anesthesia completely prevented the anesthesia-induced deficits in spatial learning and memory and the long-term neurobehavioral changes tested 65 days after exposure to anesthesia in 3xTg-AD mice. These results indicate that aging and AD-like brain pathology increase the vulnerability to cognitive impairment after anesthesia and that intranasal treatment with insulin can prevent anesthesia-induced cognitive impairment.

References Powered by Scopus

Place navigation impaired in rats with hippocampal lesions

5298Citations
N/AReaders
Get full text

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial

1094Citations
N/AReaders
Get full text

Intranasal delivery to the central nervous system: Mechanisms and experimental considerations

1032Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Intranasal insulin in Alzheimer's disease: Food for thought

82Citations
N/AReaders
Get full text

Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease

76Citations
N/AReaders
Get full text

MicroRNA-96 is responsible for sevoflurane-induced cognitive dysfunction in neonatal rats via inhibiting IGF1R

26Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chen, Y., Dai, C. L., Wu, Z., Iqbal, K., Liu, F., Zhang, B., & Gong, C. X. (2017). Intranasal insulin prevents anesthesia-induced cognitive impairment and chronic neurobehavioral changes. Frontiers in Aging Neuroscience, 9(MAY). https://doi.org/10.3389/fnagi.2017.00136

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

64%

Researcher 4

29%

Professor / Associate Prof. 1

7%

Readers' Discipline

Tooltip

Neuroscience 6

43%

Medicine and Dentistry 5

36%

Psychology 2

14%

Pharmacology, Toxicology and Pharmaceut... 1

7%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free